Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study

The primary objective of the study was to clarify whether the use of the oral contraceptive 2 mg dienogest/30 microg ethinylestradiol (DNG/EE) is associated with a higher risk of venous thromboembolism (VTE) than the use of other combined oral low-dose contraceptives (i.e. containing < or =30 mic...

Full description

Saved in:

Bibliographic Details
Published in:	The journal of family planning and reproductive health care Vol. 36; no. 3; p. 123
Main Authors:	Dinger, Jürgen, Assmann, Anita, Möhner, Sabine, Minh, Thai Do
Format:	Journal Article
Language:	English
Published:	England 01-07-2010
Subjects:	Adolescent Adult Androstenes - administration & dosage Androstenes - adverse effects Case-Control Studies Contraceptives, Oral - administration & dosage Contraceptives, Oral - adverse effects Estrogens - administration & dosage Estrogens - adverse effects Ethinyl Estradiol - administration & dosage Ethinyl Estradiol - adverse effects Female Germany - epidemiology Humans Levonorgestrel - administration & dosage Levonorgestrel - adverse effects Logistic Models Middle Aged Mineralocorticoid Receptor Antagonists - administration & dosage Mineralocorticoid Receptor Antagonists - adverse effects Nandrolone - administration & dosage Nandrolone - adverse effects Nandrolone - analogs & derivatives Risk Factors Venous Thromboembolism - chemically induced Venous Thromboembolism - epidemiology Young Adult Germany
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!